Advisory Board August 6, 2024

GLP-1 drugs are used to treat diabetes and obesity, but new studies suggest that the drugs could also be used in other ways, such as helping smokers quit and protecting the brain against Alzheimer’s.

Resource library: Weight management and obesity care

GLP-1 drugs could help with smoking cessation

In a new study published in the Annals of Internal Medicine, researchers found that patients with type 2 diabetes and tobacco use disorder (TUD) who used the GLP-1 drug semaglutide, also known as Ozempic and Wegovy, were less likely to need medical care for TUD than those who used other diabetes drugs.

For the study, researchers emulated seven target trials among 222,942 eligible patients with type 2 diabetes and TUD. The researchers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Patient / Consumer, Pharma / Biotech, Provider, Trends
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article